|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/574 | (2006.01) |
| G01N 33/57449 | (2013.01) |
| (11) | Patento numeris | 3874274 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19809947.5 |
| Europos patento paraiškos padavimo data | 2019-10-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-09-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-01-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2019/059218 |
| Data | 2019-10-31 |
| (87) | Numeris | WO 2020/092808 |
| Data | 2020-05-07 |
| (30) | Numeris | Data | Šalis |
| 201862753274 P | 2018-10-31 | US |
| (72) |
ALIFERIS, Konstantinos , US
WINTERHOFF, Boris Jan nils , US
MA, Sisi , US
WANG, Jinhua , US
|
| (73) |
Regents of the University of Minnesota ,
600 McNamara Alumni Center
200 Oak Street SE, Minneapolis, MN 55455-2020,
US
|
| (54) | METHODS FOR PREDICTING A RESPONSE TO BEVACIZUMAB OR PLATINUM-BASED CHEMOTHERAPY OR BOTH IN PATIENTS WITH OVARIAN CANCER |
| METHODS FOR PREDICTING A RESPONSE TO BEVACIZUMAB OR PLATINUM-BASED CHEMOTHERAPY OR BOTH IN PATIENTS WITH OVARIAN CANCER |